Maridea Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$257K Buy
709
+77
+12% +$26.4K 0.03% 464
2026
Q1
$222K Sell
632
-664
-51% -$237K 0.03% 415
2025
Q4
$424K Buy
1,296
+573
+79% +$182K 0.06% 277
2025
Q3
$219K Buy
+723
New +$210K 0.03% 392

Other funds holding AMGN

Maridea Wealth Management's AMGN Position: Q2 2026 in Review

Maridea Wealth Management increased its Amgen (AMGN) stake by 12% in Q2 2026, buying an estimated $26.4K and bringing the position to 709 shares worth $257K. The position accounts for 0.03% of the portfolio, ranked #464.

Maridea Wealth Management first reported a position in AMGN in Q3 2025 and has held it in 4 quarters since. The position peaked at $424K in Q4 2025. 3,160 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Maridea Wealth Management held 709 shares of Amgen worth $257K as of Q2 2026.
  • Maridea Wealth Management bought 77 Amgen shares in Q2 2026, an estimated $26.4K.
  • Amgen made up 0.03% of Maridea Wealth Management's portfolio in Q2 2026, its #464 holding.
  • Maridea Wealth Management first reported a position in Amgen in Q3 2025 and has held it in 4 quarters since.
  • Maridea Wealth Management's Amgen position peaked at $424K in Q4 2025.
  • 3,160 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Maridea Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.